Quantexa Completes USD 175 million Series F Investment Round, led by Teachers' Venture Growth
The funding will be used to develop new initiatives, strengthen Quantexa's platform innovation and drive further growth in North America
LONDON and NEW YORK, March 05, 2025 (GLOBE NEWSWIRE) -- Quantexa, a global leader in Decision Intelligence ('DI') solutions for the public and private sectors, announced today that it has completed a USD 175 million Series F investment round, led by Teachers' Venture Growth ('TVG').
The latest round values the British tech company at USD 2.6 billion and this milestone is fueling Quantexa's progress against its mission to help enterprises and government agencies across multiple markets stay ahead in the race for AI-driven DI.
The round was led by TVG, which is part of the CAD 255 billion international investor Ontario Teachers' Pension Plan, with existing investors participating, including British Patient Capital. *As part of this funding, Ara Yeromian, Managing Director at TVG, will join Quantexa's board, which includes representation from existing investors (Warburg Pincus, Dawn Capital, BNY, Evolution Equity Partners, AlbionVC, and HSBC).
Following this investment round, Quantexa will bolster its platform innovation efforts to elevate experiences for existing clients, create new partnerships and alliances, deepen its presence in North America and pursue selected M&A opportunities. TVG will leverage its expertise in successfully scaling high-growth AI and software companies, along with its extensive network, to support Quantexa's strategic international expansion and growth plans.
This Series F investment comes just months after Quantexa achieved Centaur status, joining an elite group of SaaS businesses recognized for surpassing USD 100 million in ARR.
Avid Larizadeh Duggan, Senior Managing Director and Head of TVG in EMEA, said: ' Businesses today need to build trusted data foundations to enable AI-enhanced decision making, to drive real world impact. Quantexa is revolutionizing how they do this. At TVG, we invest in high-growth, game-changing companies, led by visionary leaders making a global difference. Quantexa's impressive track record, expanding customer base, and bold approach to data and AI innovation make it a natural fit for our portfolio. We're excited to support Vishal, and his world-class team scale the company internationally as they continue helping industry-leading organizations embrace AI-driven decision-making with confidence.'
The Next Step for One of AI's Fastest Rising Players
As Quantexa works to further cement its leadership in the DI category, the company is fast-tracking its Microsoft partnership, launching an AI-powered workload for Microsoft Fabric and a cloud-native AML solution for U.S. mid-market banks via Azure Marketplace. Additionally, Quantexa is expanding its Public Sector Business Unit, doubling down on growing global demand, helping government agencies use structured and unstructured data to safely deploy AI across a range of uses cases.
Quantexa's rapid growth underscores the demand for its DI Platform, helping enterprises and government agencies scale AI and data initiatives with greater speed and success. With nearly 40% license revenue growth and 23 new customers added in 2024, Quantexa's reach now extends beyond financial services, with revenue from insurance, TMTE, and the public sector. The company has a growing global footprint of 16 offices and more than 800 employees.
Vishal Marria, Founder and CEO of Quantexa, said: 'AI is a once-in-a-generation technology transforming industries, redefining operations, and creating entirely new processes. From day one, Quantexa has been at the forefront of this revolution, helping enterprises create trusted, curated data to unlock AI's full potential. This latest investment reflects investors' embracing our vision and committing to join our journey as we accelerate innovation, platform deployments, and amplify the value we deliver to clients and the broader ecosystem. With the continued support of our investors, now including T VG, we are poised to push the boundaries of AI by harnessing the power of trusted data, reinforcing our leadership in this rapidly evolving landscape.'
* Ara Yeromian 's appointment to Quantexa's Board is subject to regulatory approval.
About Quantexa
Quantexa is a global AI, data and analytics software company pioneering Decision Intelligence to empower organizations to make trusted operational decisions with data in context. Using the latest advancements in AI, Quantexa's Decision Intelligence platform helps organizations uncover hidden risk and new opportunities by unifying siloed data and turning it into the most trusted, reusable resource. It solves major challenges across data management, customer intelligence, KYC, financial crime, risk, fraud, and security, throughout the customer lifecycle.
The Quantexa Decision Intelligence Platform enhances operational performance with over 90% more accuracy and 60 times faster analytical model resolution than traditional approaches. An independently commissioned Forrester TEI study on Quantexa's Decision Intelligence Platform found that customers saw a three-year 228% ROI. Founded in 2016, Quantexa now has over 800 employees and thousands of platform users working with billions of transactions and data points across the world. For more information visit www.quantexa.com or follow us on LinkedIn.
About Teachers' Venture Growth
Teachers' Venture Growth (TVG) focuses on late-stage venture and growth equity investments in cutting-edge technology companies worldwide. We partner with founders with bold missions, looking to expand their product offering, scale geographically, and become the leaders in their markets. We bring long-term thinking and active investing to help build better businesses and a better world. We think globally and act locally through our direct presence across Europe, North America and Asia.
TVG is part of the Ontario Teachers' Pension Plan Board (Ontario Teachers'), a global investor with net assets of CAD 255.8 billion as of June 30, 2024. We invest in more than 50 countries in a broad array of assets including public and private equities, fixed income, credit, commodities, natural resources, infrastructure, real estate and venture growth to deliver retirement income for 340,000 working members and pensioners.
Our more than 450 investment professionals operate in key financial centres around the world and bring deep expertise in a broad range of sectors and industries. We are a fully funded defined benefit pension plan and have earned an annual total-fund net return of 9.3% since the plan's founding in 1990. At Ontario Teachers', we don't just invest to make a return, we invest to shape a better future for the teachers we serve, the businesses we back, and the world we live in. For more information, visit otpp.com/teachersventuregrowth and follow us on LinkedIn.
- or -
Teachers' Venture Growth
Kekst CNC
Alisha Prakash
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
San Francisco Chronicle
an hour ago
- San Francisco Chronicle
Microsoft employee protests lead to arrests as company reviews its work with Israel's military
REDMOND, Wash. (AP) — Worker-led protests erupted at Microsoft headquarters this week as the tech company promises an 'urgent' review of the Israeli military's use of its technology during the ongoing war in Gaza. A second day of protests at the Microsoft campus on Wednesday called for the tech giant to immediately cut its business ties with Israel. The police department began making arrests after Microsoft said the protesters were trespassing. 'We said, 'Please leave or you will be arrested,' and they chose not to leave so they were detained,' said police spokesperson Jill Green. Microsoft late last week said it was tapping a law firm to investigate allegations reported by British newspaper The Guardian that the Israeli Defense Forces used Microsoft's Azure cloud computing platform to store phone call data obtained through the mass surveillance of Palestinians in Gaza and the West Bank. 'Microsoft's standard terms of service prohibit this type of usage," the company said in a statement posted Friday, adding that the report raises 'precise allegations that merit a full and urgent review.' The company said it will share the findings after law firm Covington & Burling completes its review. The promised review was insufficient for the employee-led No Azure for Apartheid group, which for months has protested Microsoft's supplying the Israeli military with technology used for its war against Hamas in Gaza. In February, The Associated Press revealed previously unreported details about the American tech giant's close partnership with the Israeli Ministry of Defense, with military use of commercial AI products skyrocketing by nearly 200 times after the deadly Oct. 7, 2023, Hamas attack. The AP reported that the Israeli military uses Azure to transcribe, translate and process intelligence gathered through mass surveillance, which can then be cross-checked with Israel's in-house AI-enabled targeting systems. Following The AP's report, Microsoft acknowledged the military applications but said a review it commissioned found no evidence that its Azure platform and artificial intelligence technologies were used to target or harm people in Gaza. Microsoft did not share a copy of that review or say who conducted it. Microsoft in May fired an employee who interrupted a speech by CEO Satya Nadella to protest the contracts, and in April, fired two others who interrupted the company's 50th anniversary celebration.
The Hill
an hour ago
- The Hill
Microsoft employee protests lead to arrests as company reviews its work with Israel's military
REDMOND, Wash. (AP) — Worker-led protests erupted at Microsoft headquarters this week as the tech company promises an 'urgent' review of the Israeli military's use of its technology during the ongoing war in Gaza. A second day of protests at the Microsoft campus on Wednesday called for the tech giant to immediately cut its business ties with Israel. The police department began making arrests after Microsoft said the protesters were trespassing. 'We said, 'Please leave or you will be arrested,' and they chose not to leave so they were detained,' said police spokesperson Jill Green. Microsoft late last week said it was tapping a law firm to investigate allegations reported by British newspaper The Guardian that the Israeli Defense Forces used Microsoft's Azure cloud computing platform to store phone call data obtained through the mass surveillance of Palestinians in Gaza and the West Bank. 'Microsoft's standard terms of service prohibit this type of usage,' the company said in a statement posted Friday, adding that the report raises 'precise allegations that merit a full and urgent review.' The company said it will share the findings after law firm Covington & Burling completes its review. The promised review was insufficient for the employee-led No Azure for Apartheid group, which for months has protested Microsoft's supplying the Israeli military with technology used for its war against Hamas in Gaza. In February, The Associated Press revealed previously unreported details about the American tech giant's close partnership with the Israeli Ministry of Defense, with military use of commercial AI products skyrocketing by nearly 200 times after the deadly Oct. 7, 2023, Hamas attack. The AP reported that the Israeli military uses Azure to transcribe, translate and process intelligence gathered through mass surveillance, which can then be cross-checked with Israel's in-house AI-enabled targeting systems. Following The AP's report, Microsoft acknowledged the military applications but said a review it commissioned found no evidence that its Azure platform and artificial intelligence technologies were used to target or harm people in Gaza. Microsoft did not share a copy of that review or say who conducted it. Microsoft in May fired an employee who interrupted a speech by CEO Satya Nadella to protest the contracts, and in April, fired two others who interrupted the company's 50th anniversary celebration.
Yahoo
2 hours ago
- Yahoo
Larkspur Biosciences Announces Discovery of LRK-4189, a First-in-Class Degrader of the Lipid Kinase PIP4K2C, for the Treatment of Microsatellite Stable (MSS) Colorectal Cancer at the ACS Fall 2025 Meeting
First-in-human, Phase 1 Study of LRK-4189 to Begin in the Fourth Quarter CAMBRIDGE, Mass., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Larkspur Biosciences, a company pioneering a new wave in cancer therapy that destroys tumors by targeting cancer cell fitness, today announced the discovery of LRK-4189, a first-in-class degrader of the lipid kinase PIP4K2C for the treatment of microsatellite stable (MSS) colorectal cancer (CRC) and other solid tumors. The announcement was made at a presentation Larkspur was invited to give at the prestigious MEDI First Time Disclosures: Breakthroughs on New Medicines session at ACS Fall 2025, a meeting of the American Chemical Society in Washington, DC. Cancer cells maintain their fitness by developing survival adaptations that foster escape from intrinsic and extrinsic mechanisms of cell death in conditions of stress. Phosphatidylinositol 5-phosphate 4-kinase, type II, gamma (PIP4K2C) is a lipid kinase associated with poor outcomes in a range of cancers including CRC and breast cancers. PIP4K2C is co-opted by cancer cells to increase their fitness by evading immune surveillance and adapting to stress. 'Genetic studies have long highlighted PIP4K2C as a key player in cancer stress adaptation, but its extremely low kinase activity made it resistant to conventional inhibition approaches,' said Catherine Sabatos-Peyton, PhD, CEO of Larkspur Biosciences. 'With our novel degrader, LRK-4189, we've finally unlocked this critical pathway. By reducing cancer cell fitness, triggering intrinsic apoptosis, and engaging the immune system to clear residual tumor cells, LRK-4189 has the potential to overcome the limitations of earlier therapies. We're excited to advance this promising therapy to the clinic later this year.' According to the American Cancer Society, in the United States, approximately 150,000 cases of CRC are diagnosed annually, with MSS CRC accounting for about 85% of all CRC cases. About LRK-4189 LRK-4189 is an orally bioavailable, selective degrader of PIP4K2C with subnanomolar potency in primary human cells. LRK-4189-mediated degradation of PIP4K2C leads to intrinsic cancer cell death and activates interferon signaling, triggering multiple killing mechanisms in difficult-to-treat MSS CRC cells. In vivo, LRK-4189 demonstrates dose dependent PKPD with single agent efficacy in multiple models of CRC and synergy with first-line standard of care chemotherapy. In primary human CRC patient-derived spheroids, 50% of patient samples respond to LRK-4189 with a preferential response in MSS CRC, which compares favorably to benchmark cetuximab in the same platform (35%). Cetuximab may be either a first- or second-line treatment in people with RAS wild type CRC. LRK-4189 has completed IND-enabling studies and expects to initiate a Phase 1 clinical trial in Q4 2025. About Larkspur Biosciences Larkspur Biosciences is pioneering a new wave in cancer therapy that destroys tumors by targeting cancer cell fitness. Larkspur develops therapies that decrease cancer cell fitness and sensitizes the cells to intrinsic and immune-driven mechanisms of killing. The company is advancing first-in-class programs that target the adaptations cancer cells use to proliferate, invade tissue, and escape the immune system. LarkX, the company's proprietary bioinformatics platform, couples machine learning with tumor genetics to discover cancer cell fitness pathways that originate in the tumor and enrich clinical strategies for potential responders to its therapies across multiple types of cancer. Larkspur's founders include Lewis C. Cantley, PhD, professor of medicine at Dana-Farber Cancer Institute, professor of cell biology at Harvard Medical School; Vijay K. Kuchroo, DVM, PhD, professor of neurology at Harvard Medical School, senior scientist at Brigham and Women's Hospital; and Nathanael Gray, PhD, professor of chemical and systems biology at Stanford University. Visit us at and follow us on LinkedIn and X. Media Contact:Dan BoyleScientPRdan@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
